Ongoing Disclosure Notice – Selwyn Pellett

To NZX Limited; and
Name of listed issuer:EROAD Limited
Date this disclosure made:8-Jun-22
Date of last disclosure:6-Dec-21
Full name(s):Selwyn Lyle Pellett
Name of listed issuer:EROAD Limited
Name of related body corporate (if applicable):Not applicable
Position held in listed issuer:
Executive Director
Class of affected quoted financial products:
Ordinary shares in EROAD Limited
Nature of the affected relevant interest(s):Registered holder and beneficial
owner
For that relevant interest-
Number held in class before acquisition or disposal:9
Number held in class after acquisition or disposal:236,719
Current registered holder(s):Selwyn Pellett
Registered holder(s) once transfers are registered:Selwyn Pellett
Type of affected derivative:Not applicable
Class of underlying financial products:Not applicable
The notional value of the derivative (if any) or the notional amount of underlying financial products (if
any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:Not applicable
Maturity date of the derivative (if any):Not applicable
Expiry date of the derivative(if any):Not applicable
The price specified in the terms of the derivative (if any):Not applicable
Any other details needed to understand how the amount of the consideration payable under the
derivative or the value of the derivative is affected by the value of the underlying financial products:
Not applicable
Parties to the derivative:Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Total number of transactions to which notice relates:11
Date of transaction:31/05/2022, 3/06/2022, 7/06/2022
Nature of transaction:
On market purchase of 236,710.46
shares
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If
the consideration was not in cash and cannot be readily by converted into a cash value, describe the
consideration:
$580,740.14
Number of financial products to which the transaction related:236,710
If the issuer has a financial products trading policy that prohibits directors or senior managers from
trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:Not applicable
Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the
closed period:
Not applicable
Date of the prior written clearance (if any):30-May-22
Summary of other relevant interests after acquisition or disposal:
Details of affected derivative-
For that derivative,-
Details of transactions giving rise to acquisition or disposal
Details of transactions requiring disclosure-
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
Director or senior manager giving disclosure
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Class of quoted financial products:EROAD Limited ordinary shares
Nature of relevant interest:Registered holder and beneficial owner
For that relevant interest,-
Number held in class:1,835,797
Current registered holder(s):Selwyn Pellett & Tracey Herman as trustees
of the Selwyn Pellett Family Trust. Selwyn
Pellett is also a beneficary of the trust.
For a derivative relevant interest,-
Type of derivative:Not appliable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if
any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:Not applicable
Maturity date of the derivative (if any):Not applicable
Expiry date of the derivative (if any):Not applicable
The price's specified terms (if any):Not applicable
Any other details needed to understand how the amount of the consideration payable under the
derivative or the value of the derivative is affected by the value of the underlying financial products:
Not applicable
For that derivative relevant interest,-
Parties to the derivative:Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is
correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:8-Jun-22
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
8-Jun-22
Name and title of authorised person: